基于幼年皮肌炎活动指数定义幼年皮肌炎疾病活动状态的判定标准
研究利用139例随机临床试验患者数据确定JDMAI1和JDMAI2区分幼年皮肌炎无疾病活动、低、中、高疾病活动的切点,并在两个队列共488例患者中验证。JDMAI1切点为≤2.4、≤6.6、6.7-11、>11;JDMAI2为≤5.2、≤8.5、8.6-11.3、>11.3。两种切点均显示良好计量学特性,适用于临床和研究。
要点
- JDMAI1区分无、低、中、高疾病活动的切点分别为≤2.4、≤6.6、6.7-11、>11。
- JDMAI2对应切点分别为≤5.2、≤8.5、8.6-11.3、>11.3。
- 两种切点在验证队列中能强区分医生和家长主观判定的疾病活动状态。
核心结论
- JDMAI1和JDMAI2切点在验证分析中显示良好的计量学特性,适用于临床实践和研究。
研究设计与样本
- 切点定义使用139例随机临床试验患者的数据。
- 从六种JDMAI版本中选择JDMAI1(评分范围0-40)和JDMAI2(评分范围0-39)。
- 通过计算评分分布的不同百分位数和受试者工作特征曲线分析,对照外部标准确定最佳切点。
- 外部标准包括改良PRINTO临床无疾病活动标准(用于无疾病活动)和PRINTO临床试验改善水平(用于低和高疾病活动)。
- 中疾病活动切点设为低和高疾病活动切点之间的评分区间。
主要发现
- JDMAI1切点:无疾病活动≤2.4,低疾病活动≤6.6,中疾病活动6.7-11,高疾病活动>11。
- JDMAI2切点:无疾病活动≤5.2,低疾病活动≤8.5,中疾病活动8.6-11.3,高疾病活动>11.3。
- 切点能强区分由主治医师和家长主观判定的疾病活动状态、家长对疾病结局满意或不满意、疼痛水平、疲劳、身体功能损害和身体健康状况。
关键数值与推荐
- JDMAI1评分范围0-40,JDMAI2评分范围0-39。
- JDMAI1无疾病活动切点≤2.4,低疾病活动≤6.6,中疾病活动6.7-11,高疾病活动>11。
- JDMAI2无疾病活动切点≤5.2,低疾病活动≤8.5,中疾病活动8.6-11.3,高疾病活动>11.3。
临床怎么用
- 原文结论指出JDMAI1和JDMAI2切点适用于临床实践和研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and validate the cut-offs in the Juvenile DermatoMyositis Activity Index (JDMAI) to distinguish the states of inactive disease (ID), low disease activity (LDA), moderate disease activity (MDA) and high disease activity (HDA) in children with juvenile dermatomyositis (JDM). METHODS: For cut-off definition, data from 139 patients included in a randomised clinical trial were used. Among the six versions of the JDMAI, JDMA1 (score range 0-40) and JDMAI2 (score range 0-39) were selected. Optimal cut-offs were determined against external criteria by calculating different percentiles of score distribution and through receiver operating characteristic curve analysis. External criteria included the modified Pediatric Rheumatology International Trials Organization (PRINTO) criteria for clinically ID in JDM (for ID) and PRINTO levels of improvement in the clinical trial (for LDA and HDA). MDA cut-offs were set at the score interval between LDA and HDA cut-offs. Cut-off validation was conducted by assessing construct and discriminative ability in two cohorts including a total of 488 JDM patients. RESULTS: The calculated JDMAI1 cut-offs were ≤2.4 for ID, ≤6.6 for LDA, 6.7-11 for MDA and >11 for HDA. The calculated JDMAI2 cut-offs were ≤5.2 for ID, ≤8.5 for LDA, 8.6-11.3 for MDA and >11.3 for HDA. The cut-offs discriminated strongly among disease activity states defined subjectively by caring physicians and parents, parents' satisfaction or non-satisfaction with illness outcome, levels of pain, fatigue, physical functional impairment and physical well-being. CONCLUSIONS: Both JDMAI1 and JDMAI2 cut-offs revealed good metrologic properties in validation analyses and are, therefore, suited for application in clinical practice and research.
引用
- Rosina S, Consolaro A, Pistorio A, et al. Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index. RMD Open. 2024. PMID: 38307698. doi:10.1136/rmdopen-2023-003093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。